{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["FDA approved drugs", "MD simulations", "MMPBSA", "SARS-CoV-2 nsp16-nsp10 2\u2032-o-methyltransferase", "molecular docking", "molecular fingerprints", "structural similarity"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35408684", "DateCompleted": {"Year": "2022", "Month": "04", "Day": "13"}, "DateRevised": {"Year": "2023", "Month": "09", "Day": "26"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "03", "Day": "31"}], "Language": ["eng"], "ELocationID": ["2287", "10.3390/molecules27072287"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "7", "PubDate": {"Year": "2022", "Month": "Mar", "Day": "31"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Ligand and Structure-Based In Silico Determination of the Most Promising SARS-CoV-2 nsp16-nsp10 2'-<i>o</i>-Methyltransferase Complex Inhibitors among 3009 FDA Approved Drugs.", "Abstract": {"AbstractText": ["As a continuation of our earlier work against SARS-CoV-2, seven FDA-approved drugs were designated as the best SARS-CoV-2 nsp16-nsp10 2'-<i>o</i>-methyltransferase (2'OMTase) inhibitors through 3009 compounds. The in silico inhibitory potential of the examined compounds against SARS-CoV-2 nsp16-nsp10 2'-<i>o</i>-methyltransferase (PDB ID: (6W4H) was conducted through a multi-step screening approach. At the beginning, molecular fingerprints experiment with <b>SAM</b> (<i>S</i>-Adenosylmethionine), the co-crystallized ligand of the targeted enzyme, unveiled the resemblance of 147 drugs. Then, a structural similarity experiment recommended 26 compounds. Therefore, the 26 compounds were docked against 2'OMTase to reveal the potential inhibitory effect of seven promising compounds (Protirelin, (<b>1187</b>), Calcium folinate (<b>1913</b>), Raltegravir (<b>1995</b>), Regadenoson (<b>2176</b>), Ertapenem (<b>2396</b>), Methylergometrine (<b>2532</b>), and Thiamine pyrophosphate hydrochloride (<b>2612</b>)). Out of the docked ligands, Ertapenem (<b>2396</b>) showed an ideal binding mode like that of the co-crystallized ligand (<b>SAM</b>). It occupied all sub-pockets of the active site and bound the crucial amino acids. Accordingly, some MD simulation experiments (RMSD, RMSF, R<sub>g</sub>, SASA, and H-bonding) have been conducted for the 2'OMTase-Ertapenem complex over 100 ns. The performed MD experiments verified the correct binding mode of Ertapenem against 2'OMTase exhibiting low energy and optimal dynamics. Finally, MM-PBSA studies indicated that Ertapenem bonded advantageously to the targeted protein with a free energy value of -43 KJ/mol. Furthermore, the binding free energy analysis revealed the essential amino acids of 2'OMTase that served positively to the binding. The achieved results bring hope to find a treatment for COVID-19 via in vitro and in vivo studies for the pointed compounds."]}, "AuthorList": [{"Identifier": ["0000-0002-6955-2263"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry and Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Eissa", "ForeName": "Ibrahim H", "Initials": "IH"}, {"Identifier": ["0000-0001-9202-1754"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry and Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Alesawy", "ForeName": "Mohamed S", "Initials": "MS"}, {"Identifier": ["0000-0002-5153-7399"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry and Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Saleh", "ForeName": "Abdulrahman M", "Initials": "AM"}, {"Identifier": ["0000-0002-2546-8035"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, Almaarefa University, Riyadh 13713, Saudi Arabia."}], "LastName": "Elkaeed", "ForeName": "Eslam B", "Initials": "EB"}, {"Identifier": ["0000-0001-6489-6035"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah Bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia."}], "LastName": "Alsfouk", "ForeName": "Bshra A", "Initials": "BA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "El-Attar", "ForeName": "Abdul-Aziz M M", "Initials": "AMM"}, {"Identifier": ["0000-0001-8566-1980"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}, {"Identifier": [], "Affiliation": "Biopharmaceutical Products Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications (SRTA-City), Alexandria 21934, Egypt."}], "LastName": "Metwaly", "ForeName": "Ahmed M", "Initials": "AM"}], "GrantList": [{"GrantID": "PNURSP2022R142", "Agency": "Princess Nourah bint Abdulrahman University", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Ligands"}, {"RegistryNumber": "0", "NameOfSubstance": "NSP10 protein, SARS-CoV-2"}, {"RegistryNumber": "0", "NameOfSubstance": "NSP16 protein, SARS-CoV-2"}, {"RegistryNumber": "0", "NameOfSubstance": "Viral Nonstructural Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Viral Regulatory and Accessory Proteins"}, {"RegistryNumber": "7LP2MPO46S", "NameOfSubstance": "S-Adenosylmethionine"}, {"RegistryNumber": "EC 2.1.1.-", "NameOfSubstance": "Methyltransferases"}, {"RegistryNumber": "G32F6EID2H", "NameOfSubstance": "Ertapenem"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Ertapenem"}, {"QualifierName": [], "DescriptorName": "Ligands"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Methyltransferases"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": ["chemistry"], "DescriptorName": "S-Adenosylmethionine"}, {"QualifierName": ["drug effects"], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Viral Nonstructural Proteins"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Viral Regulatory and Accessory Proteins"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "WHO  WHO Coronavirus (COVID-19) Dashboard.  [(accessed on 19 January 2022)].  Available online:  https://covid19.who.int/"}, {"Citation": "Wang Q., Yang L., Jin H., Lin L. Vaccination against COVID-19: A systematic review and meta-analysis of acceptability and its predictors. Prev. Med. 2021;150:106694. doi: 10.1016/j.ypmed.2021.106694.", "ArticleIdList": ["10.1016/j.ypmed.2021.106694", "PMC8217737", "34171345"]}, {"Citation": "Chan H.S., Shan H., Dahoun T., Vogel H., Yuan S. Advancing drug discovery via artificial intelligence. Trends Pharmacol. Sci. 2019;40:592\u2013604. doi: 10.1016/j.tips.2019.06.004.", "ArticleIdList": ["10.1016/j.tips.2019.06.004", "31320117"]}, {"Citation": "Pushpakom S., Iorio F., Eyers P.A., Escott K.J., Hopper S., Wells A., Doig A., Guilliams T., Latimer J., McNamee C. Drug repurposing: Progress, challenges and recommendations. Nat. Rev. Drug Discov. 2019;18:41\u201358. doi: 10.1038/nrd.2018.168.", "ArticleIdList": ["10.1038/nrd.2018.168", "30310233"]}, {"Citation": "Sleire L., F\u00f8rde H.E., Netland I.A., Leiss L., Skeie B.S., Enger P.\u00d8. Drug repurposing in cancer. Pharmacol. Res. 2017;124:74\u201391. doi: 10.1016/j.phrs.2017.07.013.", "ArticleIdList": ["10.1016/j.phrs.2017.07.013", "28712971"]}, {"Citation": "Singh T.U., Parida S., Lingaraju M.C., Kesavan M., Kumar D., Singh R.K. Drug repurposing approach to fight COVID-19. Pharmacol. Rep. 2020;72:1479\u20131508. doi: 10.1007/s43440-020-00155-6.", "ArticleIdList": ["10.1007/s43440-020-00155-6", "PMC7474498", "32889701"]}, {"Citation": "Hong J., Bang M. Anti-inflammatory strategies for schizophrenia: A review of evidence for therapeutic applications and drug repurposing. Clin. Psychopharmacol. Neurosci. 2020;18:10. doi: 10.9758/cpn.2020.18.1.10.", "ArticleIdList": ["10.9758/cpn.2020.18.1.10", "PMC7006977", "31958901"]}, {"Citation": "Konreddy A.K., Rani G.U., Lee K., Choi Y. Recent drug-repurposing-driven advances in the discovery of novel antibiotics. Curr. Med. Chem. 2019;26:5363\u20135388. doi: 10.2174/0929867325666180706101404.", "ArticleIdList": ["10.2174/0929867325666180706101404", "29984648"]}, {"Citation": "Shirley D.-A., Sharma I., Warren C.A., Moonah S. Drug repurposing of the alcohol abuse medication disulfiram as an anti-parasitic agent. Front. Cell. Infect. Microbiol. 2021;11:165. doi: 10.3389/fcimb.2021.633194.", "ArticleIdList": ["10.3389/fcimb.2021.633194", "PMC7991622", "33777846"]}, {"Citation": "Trivedi J., Mohan M., Byrareddy S.N. Drug repurposing approaches to combating viral infections. J. Clin. Med. 2020;9:3777. doi: 10.3390/jcm9113777.", "ArticleIdList": ["10.3390/jcm9113777", "PMC7700377", "33238464"]}, {"Citation": "Westbrook J.D., Burley S.K. How structural biologists and the Protein Data Bank contributed to recent FDA new drug approvals. Structure. 2019;27:211\u2013217. doi: 10.1016/j.str.2018.11.007.", "ArticleIdList": ["10.1016/j.str.2018.11.007", "PMC7325526", "30595456"]}, {"Citation": "Grimme S., Schreiner P.R. Computational chemistry: The fate of current methods and future challenges. Angew. Chem. Int. Ed. 2018;57:4170\u20134176. doi: 10.1002/anie.201709943.", "ArticleIdList": ["10.1002/anie.201709943", "29105929"]}, {"Citation": "Amin S., Banerjee S., Singh S., Qureshi I.A., Gayen S., Jha T. First structure\u2013activity relationship analysis of SARS-CoV-2 virus main protease (Mpro) inhibitors: An endeavor on COVID-19 drug discovery. Mol. Divers. 2021;25:1827\u20131838. doi: 10.1007/s11030-020-10166-3.", "ArticleIdList": ["10.1007/s11030-020-10166-3", "PMC7782049", "33400085"]}, {"Citation": "Ranjan S., Devarapalli R., Kundu S., Saha S., Deolka S., Vangala V.R., Reddy C.M. Isomorphism: Molecular similarity to crystal structure similarity\u2019in multicomponent forms of analgesic drugs tolfenamic and mefenamic acid. IUCrJ. 2020;7:173\u2013183. doi: 10.1107/S205225251901604X.", "ArticleIdList": ["10.1107/S205225251901604X", "PMC7055380", "32148846"]}, {"Citation": "Baidya A.T., Ghosh K., Amin S.A., Adhikari N., Nirmal J., Jha T., Gayen S. In silico modelling, identification of crucial molecular fingerprints, and prediction of new possible substrates of human organic cationic transporters 1 and 2. New J. Chem. 2020;44:4129\u20134143. doi: 10.1039/C9NJ05825G.", "ArticleIdList": ["10.1039/C9NJ05825G"]}, {"Citation": "Shi Y. Support vector regression-based QSAR models for prediction of antioxidant activity of phenolic compounds. Sci. Rep. 2021;11:8806. doi: 10.1038/s41598-021-88341-1.", "ArticleIdList": ["10.1038/s41598-021-88341-1", "PMC8062522", "33888843"]}, {"Citation": "Idris M.O., Yekeen A.A., Alakanse O.S., Durojaye O.A. Computer-aided screening for potential TMPRSS2 inhibitors: A combination of pharmacophore modeling, molecular docking and molecular dynamics simulation approaches. J. Biomol. Struct. Dyn. 2021;39:5638\u20135656. doi: 10.1080/07391102.2020.1792346.", "ArticleIdList": ["10.1080/07391102.2020.1792346", "PMC7441808", "32672528"]}, {"Citation": "Lu Y., Li M. A new computer model for evaluating the selective binding affinity of phenylalkylamines to T-Type Ca2+ channels. Pharmaceuticals. 2021;14:141. doi: 10.3390/ph14020141.", "ArticleIdList": ["10.3390/ph14020141", "PMC7916697", "33578931"]}, {"Citation": "Eissa I.H., Ibrahim M.K., Metwaly A.M., Belal A., Mehany A.B., Abdelhady A.A., Elhendawy M.A., Radwan M.M., ElSohly M.A., Mahdy H.A. Design, molecular docking, in vitro, and in vivo studies of new quinazolin-4 (3H)-ones as VEGFR-2 inhibitors with potential activity against hepatocellular carcinoma. Bioorgan. Chem. 2021;107:104532. doi: 10.1016/j.bioorg.2020.104532.", "ArticleIdList": ["10.1016/j.bioorg.2020.104532", "33334586"]}, {"Citation": "Zhanzhaxina A., Suleimen Y., Metwaly A.M., Eissa I.H., Elkaeed E.B., Suleimen R., Ishmuratova M., Akatan K., Luyten W. In vitro and in silico cytotoxic and antibacterial activities of a diterpene from cousinia alata schrenk. J. Chem. 2021;2021:5542455. doi: 10.1155/2021/5542455.", "ArticleIdList": ["10.1155/2021/5542455"]}, {"Citation": "Jalmakhanbetova R., Elkaeed E.B., Eissa I.H., Metwaly A.M., Suleimen Y.M. Synthesis and molecular docking of some grossgemin amino derivatives as tubulin inhibitors targeting colchicine binding site. J. Chem. 2021;2021:5586515. doi: 10.1155/2021/5586515.", "ArticleIdList": ["10.1155/2021/5586515"]}, {"Citation": "El-Adl K., El-Helby A.-G.A., Ayyad R.R., Mahdy H.A., Khalifa M.M., Elnagar H.A., Mehany A.B., Metwaly A.M., Elhendawy M.A., Radwan M.M. Design, synthesis, and anti-proliferative evaluation of new quinazolin-4 (3H)-ones as potential VEGFR-2 inhibitors. Biorgan. Med. Chem. 2021;29:115872. doi: 10.1016/j.bmc.2020.115872.", "ArticleIdList": ["10.1016/j.bmc.2020.115872", "33214036"]}, {"Citation": "Imieje V.O., Zaki A.A., Metwaly A.M., Eissa I.H., Elkaeed E.B., Ali Z., Khan I.A., Falodun A. Antileishmanial derivatives of humulene from Asteriscus hierochunticus with in silico tubulin inhibition potential. Rec. Nat. Prod. 2021;16:150\u2013171."}, {"Citation": "Rafi M.O., Al-Khafaji K., Tok T.T., Rahman M.S. Computer-based identification of potential compounds from Salviae miltiorrhizae against Neirisaral adhesion A regulatory protein. J. Biomol. Struct. Dyn. 2020:1\u201313. doi: 10.1080/07391102.2020.1856189.", "ArticleIdList": ["10.1080/07391102.2020.1856189", "33289608"]}, {"Citation": "Parmar D.R., Soni J.Y., Guduru R., Rayani R.H., Kusurkar R.V., Vala A.G., Talukdar S.N., Eissa I.H., Metwaly A.M., Khalil A. Discovery of new anticancer thiourea-azetidine hybrids: Design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies. Biorgan. Chem. 2021;115:105206. doi: 10.1016/j.bioorg.2021.105206.", "ArticleIdList": ["10.1016/j.bioorg.2021.105206", "34339975"]}, {"Citation": "El-Adl K., Sakr H.M., Yousef R.G., Mehany A.B., Metwaly A.M., Elhendawy M.A., Radwan M.M., ElSohly M.A., Abulkhair H.S., Eissa I.H. Discovery of new quinoxaline-2 (1H)-one-based anticancer agents targeting VEGFR-2 as inhibitors: Design, synthesis, and anti-proliferative evaluation. Biorgan. Chem. 2021;114:105105. doi: 10.1016/j.bioorg.2021.105105.", "ArticleIdList": ["10.1016/j.bioorg.2021.105105", "34175720"]}, {"Citation": "Suleimen Y.M., Metwaly A.M., Mostafa A.E., Elkaeed E.B., Liu H.-W., Basnet B.B., Suleimen R.N., Ishmuratova M.Y., Turdybekov K.M., Van Hecke K. Isolation, Crystal Structure, and In Silico Aromatase Inhibition Activity of Ergosta-5, 22-dien-3\u03b2-ol from the Fungus Gyromitra esculenta. J. Chem. 2021;2021:5529786. doi: 10.1155/2021/5529786.", "ArticleIdList": ["10.1155/2021/5529786"]}, {"Citation": "Yousef R.G., Sakr H.M., Eissa I.H., Mehany A.B., Metwaly A.M., Elhendawy M.A., Radwan M.M., ElSohly M.A., Abulkhair H.S., El-Adl K. New quinoxaline-2 (1 H)-ones as potential VEGFR-2 inhibitors: Design, synthesis, molecular docking, ADMET profile and anti-proliferative evaluations. New J. Chem. 2021;45:16949\u201316964. doi: 10.1039/D1NJ02509K.", "ArticleIdList": ["10.1039/D1NJ02509K", "34175720"]}, {"Citation": "Amer H.H., Alotaibi S.H., Trawneh A.H., Metwaly A.M., Eissa I.H. Anticancer activity, spectroscopic and molecular docking of some new synthesized sugar hydrazones, Arylidene and \u03b1-Aminophosphonate derivatives. Arab. J. Chem. 2021;14:103348. doi: 10.1016/j.arabjc.2021.103348.", "ArticleIdList": ["10.1016/j.arabjc.2021.103348"]}, {"Citation": "Husain A., Farooqui A., Khanam A., Sharma S., Mahfooz S., Shamim A., Akhter F., Alatar A.A., Faisal M., Ahmad S. Physicochemical characterization of C-phycocyanin from Plectonema sp. and elucidation of its bioactive potential through in silico approach. Cell. Mol. Biol. 2021;67:68\u201382. doi: 10.14715/cmb/2021.67.4.8.", "ArticleIdList": ["10.14715/cmb/2021.67.4.8", "35809301"]}, {"Citation": "Mohammed S.O., El Ashry E.S.H., Khalid A., Amer M.R., Metwaly A.M., Eissa I.H., Elkaeed E.B., Elshobaky A., Hafez E.E. Expression, Purification, and Comparative Inhibition of Helicobacter pylori Urease by Regio-Selectively Alkylated Benzimidazole 2-Thione Derivatives. Molecules. 2022;27:865. doi: 10.3390/molecules27030865.", "ArticleIdList": ["10.3390/molecules27030865", "PMC8838460", "35164122"]}, {"Citation": "Imieje V.O., Zaki A.A., Metwaly A.M., Mostafa A.E., Elkaeed E.B., Falodun A. Comprehensive In Silico Screening of the Antiviral Potentialities of a New Humulene Glucoside from Asteriscus hierochunticus against SARS-CoV-2. J. Chem. 2021;2021:5541876. doi: 10.1155/2021/5541876.", "ArticleIdList": ["10.1155/2021/5541876"]}, {"Citation": "El-Demerdash A., Metwaly A.M., Hassan A., El-Aziz A., Mohamed T., Elkaeed E.B., Eissa I.H., Arafa R.K., Stockand J.D. Comprehensive virtual screening of the antiviral potentialities of marine polycyclic guanidine alkaloids against SARS-CoV-2 (COVID-19) Biomolecules. 2021;11:460. doi: 10.3390/biom11030460.", "ArticleIdList": ["10.3390/biom11030460", "PMC8003478", "33808721"]}, {"Citation": "Jalmakhanbetova R.I., Suleimen Y.M., Oyama M., Elkaeed E.B., Eissa I., Suleimen R.N., Metwaly A.M., Ishmuratova M.Y. Isolation and In Silico Anti-COVID-19 Main Protease (Mpro) Activities of Flavonoids and a Sesquiterpene Lactone from Artemisia sublessingiana. J. Chem. 2021;2021:5547013. doi: 10.1155/2021/5547013.", "ArticleIdList": ["10.1155/2021/5547013"]}, {"Citation": "Suleimen Y.M., Jose R.A., Suleimen R.N., Arenz C., Ishmuratova M., Toppet S., Dehaen W., Alsfouk A.A., Elkaeed E.B., Eissa I.H., et al. Isolation and In Silico Anti-SARS-CoV-2 Papain-Like Protease Potentialities of Two Rare 2-Phenoxychromone Derivatives from Artemisia spp. Molecules. 2022;27:1216. doi: 10.3390/molecules27041216.", "ArticleIdList": ["10.3390/molecules27041216", "PMC8879996", "35209006"]}, {"Citation": "Alesawy M.S., Abdallah A.E., Taghour M.S., Elkaeed E.B., H Eissa I., Metwaly A.M. In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (Mpro) Molecules. 2021;26:2806. doi: 10.3390/molecules26092806.", "ArticleIdList": ["10.3390/molecules26092806", "PMC8126168", "34068579"]}, {"Citation": "Eissa I.H., Khalifa M.M., Elkaeed E.B., Hafez E.E., Alsfouk A.A., Metwaly A.M. In Silico Exploration of Potential Natural Inhibitors against SARS-Cov-2 nsp10. Molecules. 2021;26:6151. doi: 10.3390/molecules26206151.", "ArticleIdList": ["10.3390/molecules26206151", "PMC8539059", "34684735"]}, {"Citation": "Alesawy M.S., Elkaeed E.B., Alsfouk A.A., Metwaly A.M., Eissa I. In Silico Screening of Semi-Synthesized Compounds as Potential Inhibitors for SARS-CoV-2 Papain-like Protease: Pharmacophoric Features, Molecular Docking, ADMET, Toxicity and DFT Studies. Molecules. 2021;26:6593. doi: 10.3390/molecules26216593.", "ArticleIdList": ["10.3390/molecules26216593", "PMC8588135", "34771004"]}, {"Citation": "FDA-Approved Drug Library.  [(accessed on 19 November 2021)].  Available online:  https://www.selleckchem.com/screening/fda-approved-drug-library.html."}, {"Citation": "Briem H., Kuntz I.D. Molecular similarity based on DOCK-generated fingerprints. J. Med. Chem. 1996;39:3401\u20133408. doi: 10.1021/jm950800y.", "ArticleIdList": ["10.1021/jm950800y", "8765524"]}, {"Citation": "Vidal D., Garcia-Serna R., Mestres J. Chemoinformatics and Computational Chemical Biology. Springer; Berlin/Heidelberg, Germany: 2011. Ligand-based approaches to in silico pharmacology; pp. 489\u2013502.", "ArticleIdList": ["20838981"]}, {"Citation": "Hassell A.M., An G., Bledsoe R.K., Bynum J.M., Carter H.L., Deng S.-J., Gampe R.T., Grisard T.E., Madauss K.P., Nolte R.T. Crystallization of protein\u2013ligand complexes. Acta Crystallogr. Sect. D Biol. Crystallogr. 2007;63:72\u201379. doi: 10.1107/S0907444906047020.", "ArticleIdList": ["10.1107/S0907444906047020", "PMC2483499", "17164529"]}, {"Citation": "Chu H., He Q.-X., Wang J., Hu Y., Wang Y.-Q., Lin Z.-H. In silico design of novel benzohydroxamate-based compounds as inhibitors of histone deacetylase 6 based on 3D-QSAR, molecular docking, and molecular dynamics simulations. New J. Chem. 2020;44:21201\u201321210. doi: 10.1039/D0NJ04704J.", "ArticleIdList": ["10.1039/D0NJ04704J"]}, {"Citation": "Ieritano C., Campbell J.L., Hopkins W.S. Predicting differential ion mobility behaviour in silico using machine learning. Analyst. 2021;146:4737\u20134743. doi: 10.1039/D1AN00557J.", "ArticleIdList": ["10.1039/D1AN00557J", "34212943"]}, {"Citation": "Taha M., Ismail N.H., Ali M., Rashid U., Imran S., Uddin N., Khan K.M. Molecular hybridization conceded exceptionally potent quinolinyl-oxadiazole hybrids through phenyl linked thiosemicarbazide antileishmanial scaffolds: In silico validation and SAR studies. Biorgan. Chem. 2017;71:192\u2013200. doi: 10.1016/j.bioorg.2017.02.005.", "ArticleIdList": ["10.1016/j.bioorg.2017.02.005", "28228228"]}, {"Citation": "Opo F.A.D.M., Rahman M.M., Ahammad F., Ahmed I., Bhuiyan M.A., Asiri A.M. Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting XIAP protein. Sci. Rep. 2021;11:4049. doi: 10.1038/s41598-021-83626-x.", "ArticleIdList": ["10.1038/s41598-021-83626-x", "PMC7892887", "33603068"]}, {"Citation": "Durant J.L., Leland B.A., Henry D.R., Nourse J.G. Reoptimization of MDL keys for use in drug discovery. J. Chem. Inf. Comput. Sci. 2002;42:1273\u20131280. doi: 10.1021/ci010132r.", "ArticleIdList": ["10.1021/ci010132r", "12444722"]}, {"Citation": "Maggiora G., Vogt M., Stumpfe D., Bajorath J. Molecular similarity in medicinal chemistry: Miniperspective. J. Med. Chem. 2014;57:3186\u20133204. doi: 10.1021/jm401411z.", "ArticleIdList": ["10.1021/jm401411z", "24151987"]}, {"Citation": "Bender A., Glen R.C. Molecular similarity: A key technique in molecular informatics. Org. Biomol. Chem. 2004;2:3204\u20133218. doi: 10.1039/b409813g.", "ArticleIdList": ["10.1039/b409813g", "15534697"]}, {"Citation": "Sullivan K.M., Enoch S.J., Ezendam J., Sewald K., Roggen E.L., Cochrane S. An adverse outcome pathway for sensitization of the respiratory tract by low-molecular-weight chemicals: Building evidence to support the utility of in vitro and in silico methods in a regulatory context. Appl. Vitr. Toxicol. 2017;3:213\u2013226. doi: 10.1089/aivt.2017.0010.", "ArticleIdList": ["10.1089/aivt.2017.0010"]}, {"Citation": "Altamash T., Amhamed A., Aparicio S., Atilhan M. Effect of hydrogen bond donors and acceptors on CO2 absorption by deep eutectic solvents. Processes. 2020;8:1533. doi: 10.3390/pr8121533.", "ArticleIdList": ["10.3390/pr8121533"]}, {"Citation": "Wan Y., Tian Y., Wang W., Gu S., Ju X., Liu G. In silico studies of diarylpyridine derivatives as novel HIV-1 NNRTIs using docking-based 3D-QSAR, molecular dynamics, and pharmacophore modeling approaches. RSC Adv. 2018;8:40529\u201340543. doi: 10.1039/C8RA06475J.", "ArticleIdList": ["10.1039/C8RA06475J", "PMC9091378", "35557880"]}, {"Citation": "Turchi M., Cai Q., Lian G. An evaluation of in-silico methods for predicting solute partition in multiphase complex fluids\u2014A case study of octanol/water partition coefficient. Chem. Eng. Sci. 2019;197:150\u2013158. doi: 10.1016/j.ces.2018.12.003.", "ArticleIdList": ["10.1016/j.ces.2018.12.003"]}, {"Citation": "Escamilla-Guti\u00e9rrez A., Ribas-Aparicio R.M., C\u00f3rdova-Espinoza M.G., Castel\u00e1n-Vega J.A. In silico strategies for modeling RNA aptamers and predicting binding sites of their molecular targets. Nucleosides Nucleotides Nucleic Acids. 2021;40:798\u2013807. doi: 10.1080/15257770.2021.1951754.", "ArticleIdList": ["10.1080/15257770.2021.1951754", "34323642"]}, {"Citation": "Kaushik A.C., Kumar A., Bharadwaj S., Chaudhary R., Sahi S. Bioinformatics Techniques for Drug Discovery. Springer; Berlin/Heidelberg, Germany: 2018. Ligand-Based Approach for In-silico Drug Designing; pp. 11\u201319."}, {"Citation": "Zhang H., Ren J.-X., Ma J.-X., Ding L. Development of an in silico prediction model for chemical-induced urinary tract toxicity by using na\u00efve Bayes classifier. Mol. Divers. 2019;23:381\u2013392. doi: 10.1007/s11030-018-9882-8.", "ArticleIdList": ["10.1007/s11030-018-9882-8", "30294757"]}, {"Citation": "Sheridan R.P., Kearsley S.K. Why do we need so many chemical similarity search methods? Drug Discov. Today. 2002;7:903\u2013911. doi: 10.1016/S1359-6446(02)02411-X.", "ArticleIdList": ["10.1016/S1359-6446(02)02411-X", "12546933"]}, {"Citation": "MOE  MOE User Guide.  [(accessed on 1 October 2021)].  Available online:  https://www.easa.europa.eu/sites/default/files/dfu/B01.UG_.CAO_.00024-008%20User%20Guide%20for%20Maintenance%20Organisation%20Exposition.PDF."}, {"Citation": "Rosas-Lemus M., Minasov G., Shuvalova L., Inniss N.L., Kiryukhina O., Brunzelle J., Satchell K.J. High-resolution structures of the SARS-CoV-2 2\u2032-O-methyltransferase reveal strategies for structure-based inhibitor design. Sci. Signal. 2020;13:eabe1202. doi: 10.1126/scisignal.abe1202.", "ArticleIdList": ["10.1126/scisignal.abe1202", "PMC8028745", "32994211"]}, {"Citation": "Sousa S.F., Fernandes P.A., Ramos M.J. Protein\u2013ligand docking: Current status and future challenges. Proteins Struct. Funct. Bioinform. 2006;65:15\u201326. doi: 10.1002/prot.21082.", "ArticleIdList": ["10.1002/prot.21082", "16862531"]}, {"Citation": "Hollingsworth S.A., Dror R.O. Molecular dynamics simulation for all. Neuron. 2018;99:1129\u20131143. doi: 10.1016/j.neuron.2018.08.011.", "ArticleIdList": ["10.1016/j.neuron.2018.08.011", "PMC6209097", "30236283"]}, {"Citation": "Liu X., Shi D., Zhou S., Liu H., Liu H., Yao X. Molecular dynamics simulations and novel drug discovery. Expert Opin. Drug Discov. 2018;13:23\u201337. doi: 10.1080/17460441.2018.1403419.", "ArticleIdList": ["10.1080/17460441.2018.1403419", "29139324"]}, {"Citation": "Kuzmanic A., Zagrovic B. Determination of ensemble-average pairwise root mean-square deviation from experimental B-factors. Biophys. J. 2010;98:861\u2013871. doi: 10.1016/j.bpj.2009.11.011.", "ArticleIdList": ["10.1016/j.bpj.2009.11.011", "PMC2830444", "20197040"]}, {"Citation": "Protein Data Bank. 2021.  [(accessed on 5 January 2022)].  Available online:  https://www.rcsb.org/structure/4OW0."}, {"Citation": "Jo S., Kim T., Iyer V.G., Im W. CHARMM-GUI: A web-based graphical user interface for CHARMM. J. Comput. Chem. 2008;29:1859\u20131865. doi: 10.1002/jcc.20945.", "ArticleIdList": ["10.1002/jcc.20945", "18351591"]}, {"Citation": "Brooks B.R., Brooks C.L., III., Mackerell A.D., Jr., Nilsson L., Petrella R.J., Roux B., Won Y., Archontis G., Bartels C., Boresch S., et al. CHARMM: The biomolecular simulation program. J. Comput. Chem. 2009;30:1545\u20131614. doi: 10.1002/jcc.21287.", "ArticleIdList": ["10.1002/jcc.21287", "PMC2810661", "19444816"]}, {"Citation": "Lee J., Cheng X., Swails J.M., Yeom M.S., Eastman P.K., Lemkul J.A., Wei S., Buckner J., Jeong J.C., Qi Y., et al. CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field. J. Chem. Theory Comput. 2016;12:405\u2013413. doi: 10.1021/acs.jctc.5b00935.", "ArticleIdList": ["10.1021/acs.jctc.5b00935", "PMC4712441", "26631602"]}, {"Citation": "Best R.B., Zhu X., Shim J., Lopes P.E., Mittal J., Feig M., Mackerell A.D., Jr. Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone phi, psi and side-chain chi(1) and chi(2) dihedral angles. J. Chem. Theory Comput. 2012;8:3257\u20133273. doi: 10.1021/ct300400x.", "ArticleIdList": ["10.1021/ct300400x", "PMC3549273", "23341755"]}, {"Citation": "Phillips J.C., Braun R., Wang W., Gumbart J., Tajkhorshid E., Villa E., Chipot C., Skeel R.D., Kale L., Schulten K. Scalable molecular dynamics with NAMD. J. Comput. Chem. 2005;26:1781\u20131802. doi: 10.1002/jcc.20289.", "ArticleIdList": ["10.1002/jcc.20289", "PMC2486339", "16222654"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "2", "Day": "23"}, {"Year": "2022", "Month": "3", "Day": "27"}, {"Year": "2022", "Month": "3", "Day": "28"}, {"Year": "2022", "Month": "4", "Day": "12", "Hour": "1", "Minute": "11"}, {"Year": "2022", "Month": "4", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "31"}], "PublicationStatus": "epublish", "ArticleIdList": ["35408684", "PMC9000629", "10.3390/molecules27072287", "molecules27072287"]}}], "PubmedBookArticle": []}